These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 5880029

  • 1. [On the behavior of some serum enzymatic activities in subjects with progressive muscular dystrophy treated with nucleotide and nucleoside substances. II. Malate dehydrogenase, glutamic oxalacetic transaminase and glutamic-pyruvic transaminase activity].
    Canani MB, Rea F, Capasso DA.
    Boll Soc Ital Biol Sper; 1965 Aug 31; 41(16):901-4. PubMed ID: 5880029
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T, Annaka S, Baba T, Kanno M.
    Iryo; 1969 Oct 31; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The treatment of muscular dystrophy with the nucleoside-nucleotide mixture Laevadosine].
    Radu H, Stenzel K, Migea S, Bordeianu L.
    Munch Med Wochenschr; 1967 Dec 22; 109(51):2702-5. PubMed ID: 4873261
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Behavior of glutamic-oxalacetic and glutamic-pyruvic transaminase activity in silicotics].
    CAPEZZUTO A.
    Folia Med (Napoli); 1962 Oct 22; 45():872-82. PubMed ID: 14018406
    [No Abstract] [Full Text] [Related]

  • 10. [New aspects of the management of progressive muscular dystrophy].
    Tilscher H, Schenk S.
    Wien Med Wochenschr; 1967 Nov 04; 117(44):1000-2. PubMed ID: 5591872
    [No Abstract] [Full Text] [Related]

  • 11. [Aspartate aminotransferase (glutamic oxalacetic transaminase) and alanine aminotransferase (glutamic pyruvic transaminase)].
    Yoneda K.
    Rinsho Byori; 2001 Nov 04; Suppl 116():72-80. PubMed ID: 11797383
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of muscular dystrophy with "Laevadosin".
    Lip P, Flanagan J, Murray P.
    Med J Aust; 1969 Jun 28; 1(26):1386. PubMed ID: 5797171
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.